Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Angela De Stefano

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Endocrine-Related Cancer|January 24, 2023
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitorsTommaso Porcelli, Raffaele Ambrosio, Maria Angela De Stefano, et al.
The Journal of Clinical Investigation|March 5, 2026
Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewalMaria Angela De Stefano, Raffaele Ambrosio, Cristina Luongo, et al.
JCO Precision Oncology|August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent MechanismsTommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case ReportCristina Luongo, Tommaso Porcelli, Francesca Sessa, et al.
Thyroid : Official Journal of the American Thyroid Association|December 3, 2025
Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid CancerMaria Angela De Stefano, Cristina Luongo, Tommaso Porcelli, et al.
Thyroid : Official Journal of the American Thyroid Association|January 21, 2023
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid HormoneCristina Luongo, Maria Angela De Stefano, Raffaele Ambrosio, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2017
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma CellsCaterina Miro, Raffaele Ambrosio, Maria Angela De Stefano, et al.
Cancers|March 22, 2020
The NANOG Transcription Factor Induces Type 2 Deiodinase Expression and Regulates the Intracellular Activation of Thyroid Hormone in Keratinocyte CarcinomasAnnarita Nappi, Emery Di Cicco, Caterina Miro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2023
Altered Thyroid Feedback Loop in Klinefelter Syndrome: From Infancy Through the Transition to AdulthoodFrancesco Carlomagno, Marianna Minnetti, Francesco Angelini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Therapeutic p63 Isoform Switching Rescues Epidermal Defects in AEC SyndromeDaniela Di Girolamo, Gloria Urciuoli, Stefano Sol, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Endocrine-Related Cancer|January 24, 2023
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitorsTommaso Porcelli, Raffaele Ambrosio, Maria Angela De Stefano, et al.
The Journal of Clinical Investigation|March 5, 2026
Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewalMaria Angela De Stefano, Raffaele Ambrosio, Cristina Luongo, et al.
JCO Precision Oncology|August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent MechanismsTommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case ReportCristina Luongo, Tommaso Porcelli, Francesca Sessa, et al.
Thyroid : Official Journal of the American Thyroid Association|December 3, 2025
Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid CancerMaria Angela De Stefano, Cristina Luongo, Tommaso Porcelli, et al.
Thyroid : Official Journal of the American Thyroid Association|January 21, 2023
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid HormoneCristina Luongo, Maria Angela De Stefano, Raffaele Ambrosio, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2017
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma CellsCaterina Miro, Raffaele Ambrosio, Maria Angela De Stefano, et al.
Cancers|March 22, 2020
The NANOG Transcription Factor Induces Type 2 Deiodinase Expression and Regulates the Intracellular Activation of Thyroid Hormone in Keratinocyte CarcinomasAnnarita Nappi, Emery Di Cicco, Caterina Miro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2023
Altered Thyroid Feedback Loop in Klinefelter Syndrome: From Infancy Through the Transition to AdulthoodFrancesco Carlomagno, Marianna Minnetti, Francesco Angelini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Therapeutic p63 Isoform Switching Rescues Epidermal Defects in AEC SyndromeDaniela Di Girolamo, Gloria Urciuoli, Stefano Sol, et al.
Pageof 3